Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ironwood Pharmaceuticals, Inc.    IRWD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about IRONWOOD PHARMACEUTICALS,
07/21 HERE’S WHAT JUST HAPPENED WITH : IRWD) and Aeterna Zentaris Inc. (NASDAQ:A..
07/20 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2017 Investor Update Call
07/20 IRONWOOD PHARMACEUTICALS : Reports Positive Top-line Results from IW-3718 Phase ..
06/08 IRONWOOD PHARMACEUTICALS : to Present at the Goldman Sachs 38th Annual Global He..
06/01 IRONWOOD PHARMACEUTICALS : to Present at the Jefferies Healthcare Conference
05/10 IRONWOOD PHARMACEUTICALS : to Present at the Bank of America Merrill Lynch Healt..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide's Effec..
05/09 IRONWOOD PHARMACEUTICALS : Presents Data Further Elucidating Linaclotide’s..
05/08 IRONWOOD PHARMACEUTICALS, INC. (NASD : IRWD) reported earnings of ($0.36) per sh..
05/08 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Results of Operations ..
05/08 IRONWOOD PHARMACEUTICALS : reports 1Q loss
05/08 IRONWOOD PHARMACEUTICALS : Provides First Quarter 2017 Investor Update
05/01 IRONWOOD PHARMACEUTICALS : to Present New Data for Linaclotide, Linaclotide Dela..
04/24 IRONWOOD PHARMACEUTICALS : to Host First Quarter 2017 Investor Update Call
04/18 IRONWOOD PHARMACEUTICALS,INC. (NASDA : IRWD) Files An 8-K Departure of Directors..
More most relevant news
All news about IRONWOOD PHARMACEUTICALS,
07/21 HERE’S WHAT JUST HAPPENED WITH : IRWD) and Aeterna Zentaris Inc. (NASDAQ:A..
07/20 IRONWOOD PHARMACEUTICALS : to Host Second Quarter 2017 Investor Update Call
07/20 IRONWOOD PHARMACEUTICALS : New Biotechnology Findings from Ironwood Pharmaceutic..
07/20 IRONWOOD PHARMACEUTICALS : Reports Positive Top-line Results from IW-3718 Phase ..
07/03 IRONWOOD PHARMACEUTICALS, INC. : Today's Research Reports on Trending Tickers: I..
06/15 IRONWOOD PHARMACEUTICALS : to Present at the Goldman Sachs 38th Annual Global He..
06/09 IRONWOOD PHARMACEUTICALS : to Present at the Jefferies Healthcare Conference
06/08 IRONWOOD PHARMACEUTICALS : to Present at the Goldman Sachs 38th Annual Global He..
06/02 IRONWOOD PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holde..
06/01 IRONWOOD PHARMACEUTICALS : to Present at the Jefferies Healthcare Conference
More news
Sector news : Biotechnology & Medical Research - NEC
01:37pDJELI LILLY AND : to Delay Arthritis Drug Application -- Market Talk
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/18 JOHNSON & JOHNSON : J&J sees sales growth in near-term; raises 2017 profit forec..
07/12 FDA panel backs Novartis' pioneering new cancer gene therapy
06/23DJOne of the Last Untapped Blockbuster Diseases? Drug Companies Race to Find a ..
06/20 Novartis eye drug works with fewer injections than rival
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
07/24 Data Put A Dent In Ironwood's Expansion Plans
07/21 Ironwood Will Press On In The Good Fight Against GERD
07/21 Why Ironwood's IW-3718 Is 'Refluxing' Into A Sea Of Red
07/21 Premarket analyst action - healthcare
07/20 Ironwood Pharmaceuticals (IRWD) IW-3718 Phase IIb Clinical Trial Results - Sl..
07/20 HEALTHCARE - TOP 5 GAINERS / LOSERS : 30
Latest Tweets
02:33pIronwood Pharmaceuticals, Inc. $IRWD Downgraded by Wood & Company to Neut.. 
01:23pIronwood Pharmaceuticals’ $IRWD “Neutral” Rating Reaffirmed at J P Morgan Cha.. 
07/24Ironwood Pharmaceuticals stock price target raised to $12 from $8 at UBS #new.. 
07/24Data Put A Dent In Ironwood's Expansion Plans  
07/23Ironwood Pharmaceuticals's outperform rating reiterated at Cowen and Company... 
More tweets
Qtime:24
Financials ($)
Sales 2017 297 M
EBIT 2017 -103 M
Net income 2017 -138 M
Debt 2017 188 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 9,18x
EV / Sales 2018 6,83x
Capitalization 2 543 M
Chart IRONWOOD PHARMACEUTICALS,
Duration : Period :
Ironwood Pharmaceuticals,  Technical Analysis Chart | IRWD | US46333X1081 | 4-Traders
Technical analysis trends IRONWOOD PHARMACEUTICALS,
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 17,7 $
Spread / Average Target 3,3%
EPS Revisions
Managers
NameTitle
Peter M. Hecht Chief Executive Officer & Director
Terrance G. McGuire Chairman
Thomas Graney Chief Financial Officer & SVP-Corporate Strategy
Mark G. Currie Chief Scientific Officer & Senior Vice President
Brian M. Cali Senior VP-Preclinical, Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
IRONWOOD PHARMACEUTICALS, INC.11.90%2 543
INCYTE CORPORATION33.86%28 314
QUINTILES IMS HOLDINGS INC19.86%19 795
LONZA GROUP31.59%16 758
CELLTRION, INC.--.--%12 650
ALKERMES PLC5.49%8 982